Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001564590-18-001529
Filing Date
2018-02-07
Accepted
2018-02-07 16:30:33
Documents
4
Effectiveness Date
2018-02-07

Document Format Files

Seq Description Document Type Size
1 S-8 2017 EQUITY INCENTIVE PLAN mygn-s8.htm S-8 133852
2 EX-5.1 mygn-ex51_7.htm EX-5.1 16244
3 EX-23.1 mygn-ex231_6.htm EX-23.1 2730
4 GRAPHIC g2018020715115238071249.jpg GRAPHIC 3011
  Complete submission text file 0001564590-18-001529.txt   158114
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: S-8 | Act: 33 | File No.: 333-222913 | Film No.: 18581499
SIC: 2835 In Vitro & In Vivo Diagnostic Substances